Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study

Zhixian Wang(Harbin Institute of Technology), Yisheng Yin(Nanjing University), Yunpeng Zhu(Tongji Hospital), Xing Li(Tongji Hospital), Jing Wang(Inserm)
Frontiers in Oncology
July 30, 2021
Cited by 12


Related Papers